...
首页> 外文期刊>Molecular and Cellular Endocrinology >Studies on sperm chromosomes in patients with severe male factor infertility undergoing assisted reproductive technology treatment.
【24h】

Studies on sperm chromosomes in patients with severe male factor infertility undergoing assisted reproductive technology treatment.

机译:重度男性不育症患者辅助生殖技术治疗的精子染色体研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the study was to determine the rate of chromosome abnormalities in testicular sperm after intracytoplasmic sperm injection due to severe male factor infertility. The study groups included patient with non-obstructive azoospermia (n=9), obstructive azoospermia (n=10), Klinefelter's syndrome (n=5) and normal controls (n=6, groups I-VI, respectively). The mean serum levels of FSH 17.5+/-8.2 (P<0.05), 3.5+/-2.6, 29.8+/-13.0 (P<0.05) and 3.1+/-0.4 mIU/ml, respectively. The rates of chromosome abnormalities were 19.6% (P<0.001), 8.2% (P<0.001), 6.3 and 1.6%, respectively. Chromosomes X and Y were significantly more involved in the aneuploidy than chromosome 18 in groups I and II. The present findings demonstrate a linkage between gonadal failure (high serum FSH levels) and sperm chromosome abnormalities. Our findings may explain the increased incidence of perinatal sex chromosome abnormalities found in severe male factor patients. Patients with non-mosaic Klinefelter's syndrome have comparable risk for sex chromosomes aneuploidy as the rest of the patients with azoospermia. Therefore, genetic screening during pregnancy or before embryo replacement should be carefully considered in severe male factor patient following in vitro fertilization (IVF).
机译:该研究的目的是确定由于严重的男性不育症而注射胞浆内精子后睾丸精子的染色体异常率。研究组包括患有非阻塞性无精子症(n = 9),阻塞性无精子症(n = 10),克氏综合征(n = 5)和正常对照组(n = 6,I-VI组)的患者。 FSH的平均血清水平分别为17.5 +/- 8.2(P <0.05),3.5 +/- 2.6、29.8 +/- 13.0(P <0.05)和3.1 +/- 0.4 mIU / ml。染色体异常率分别为19.6%(P <0.001),8.2%(P <0.001),6.3和1.6%。在I和II组中,X和Y染色体比18号染色体参与非整倍体的比例明显更高。本研究结果表明,性腺衰竭(高血清FSH水平)与精子染色体异常之间存在联系。我们的发现可能解释了在严重男性因素患者中发现的围产期性染色体异常的发生率增加。非镶嵌性Klinefelter综合征患者的性染色体非整倍性风险与其余无精子症患者相当。因此,对于重度男性因子患者,在体外受精(IVF)后,应谨慎考虑怀孕期间或胚胎移植前的基因筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号